A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine is a research paper published in npj Vaccines (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | National Institutes of Health
Grant: R44AI103983, UM1AI148684, 75N93022C00036
Bill and Melinda Gates Foundation
Grant: OPP1097535, INV-027122, INV-004809
NIAID NIH HHS
Grant: UM1 AI148684
National Institutes of Health
Grant: 2R44AI103983-06A1
A Vaccine for Schistosomiasis, "SchistoShield"
National Institutes of Health
Grant: 3UM1AI148684-03S1
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
European Commission
Grant: 815643
Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa
FWCI
3.31
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals